BioSig Technologies to present clinical observations at Venice Arrhythmias
BioSig Technologies announced the PURE EP System will be highlighted in a poster presentation at the Venice Arrhythmias conference. The poster titled, "Use of a Novel Intracardiac Signal Processing System during Mapping of Complex Cardiac Arrhythmias" is authored by Amin Al-Ahmad, M.D., Carola Gianni, M.D., Domenico G. Della Rocca, M.D., J. David Burkhardt, M.D., Rodney P. Horton, M.D., G. Joseph Gallinghouse, M.D., Patrick M. Hranitzky, M.D., Javier E. Sanchez, M.D., Luigi Di Biase, M.D. and Andrea Natale, M.D. from Texas Cardiac Arrhythmia Institute in Austin, TX. The clinical data presented in the poster was collected during two atrial fibrillation cases conducted with PURE EP System in February 2019. After conducting first clinical cases at Texas Cardiac Arrhythmia Institute in February 2019 BioSig successfully carried out further patient cases using its PURE EP System at Greenville Memorial Hospital in Greenville, SC and Indiana University School of Medicine. BioSig was recently added to the Russell 3000 Index and allowed 33 patent claims covering its PURE EP System.